.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

KETALAR Drug Profile

« Back to Dashboard

Which patents cover Ketalar, and what substitute generic drugs are available?

Ketalar is a drug marketed by Par Sterile Products and is included in one NDA.

The generic ingredient in KETALAR is ketamine hydrochloride. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ketamine hydrochloride profile page.

Summary for Tradename: KETALAR

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Bulk Api Vendors: see list14
Clinical Trials: see list84
Patent Applications: see list2,031
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:KETALAR at DailyMed

Pharmacology for Tradename: KETALAR

Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products
KETALAR
ketamine hydrochloride
INJECTABLE;INJECTION016812-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Par Sterile Products
KETALAR
ketamine hydrochloride
INJECTABLE;INJECTION016812-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Par Sterile Products
KETALAR
ketamine hydrochloride
INJECTABLE;INJECTION016812-003Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc